Metabolism and functional effects of plant-derived omega-3 fatty acids in humans

Progress in Lipid Research

Volumn 64, Issue , 2016, Pages 30-56

  Baker, Ella J ^a   Miles, Elizabeth A ^a   Burdge, Graham C ^a   Yaqoob, Parveen ^b   Calder, Philip C ^a,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Alpha linolenic acid; Fatty acid composition; Human health; Omega 3; Stearidonic acid

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIDONIC ACID;

ADIPOSE TISSUE; BLOOD PRESSURE; CARBON METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; EPIGENETICS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FOOD AVAILABILITY; FOOD INTAKE; GENETIC ASSOCIATION; HEALTH STATUS; HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; IMMUNE RESPONSE; INFLAMMATION; ISOTOPE LABELING; LIPID COMPOSITION; NONHUMAN; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; BLOOD; DIET; ERYTHROCYTE; METABOLISM; PLANT;

ALPHA-LINOLENIC ACID; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; HUMANS; PLANTS;

EID: 84981745200     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2016.07.002     Document Type: Review

References (269)

1. [1] Calder, P.C., Very long chain omega-3 (n − 3) fatty acids and human health. Eur. J. Lipid Sci. Technol. 116 (2014), 1280–1300.
2. [2] Calder, P.C., n − 3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin. Sci. (Lond.) 107 (2004), 1–11.
3. [3] Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007), 1090–1098.
4. [4] Marik, P.E., Varon, J., Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin. Cardiol. 32 (2009), 365–372.
5. [5] Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H.A., Johnson, L., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med. 160 (2014), 398–406.
6. [6] Bucher, H.C., Hengstler, P., Schindler, C., Meier, G., N − 3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 112 (2002), 298–304.
7. [7] Studer, M., Briel, M., Leimenstoll, B., Glass, T.R., Bucher, H.C., Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch. Intern. Med. 165 (2005), 725–730.
8. [8] Casula, M., Soranna, D., Catapano, A.L., Corrao, G., Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler. Suppl. 14 (2013), 243–251.
9. [9] SanGiovanni, J.P., Parra-Cabrera, S., Colditz, G.A., Berkey, C.S., Dwyer, J.T., Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 105 (2000), 1292–1298.
10. [10] Calder, P.C., PUFA, inflammatory processes and rheumatoid arthritis. Proc. Nutr. Soc. 67 (2008), 409–418.
11. [11] Barros, R., Moreira, A., Fonseca, J., Delgado, L., Castel-Branco, M.G., Haahtela, T., et al. Dietary intake of alpha-linolenic acid and low ratio of n − 6:n − 3 PUFA are associated with decreased exhaled NO and improved asthma control. Br. J. Nutr. 106 (2011), 441–450.
12. [12] Rizos, E.C., Ntzani, E.E., Bika, E., Kostapanos, M.S., Elisaf, M.S., Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308 (2012), 1024–1033.
13. [13] Kwak, S.M., Myung, S.K., Lee, Y.J., Seo, H.G., Korean Meta-analysis Study G, Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch. Intern. Med. 172 (2012), 686–694.
14. [14] Calder, P.C., Yaqoob, P., Marine omega-3 fatty acids and coronary heart disease. Curr. Opin. Cardiol. 27 (2012), 412–419.
15. [15] Ma, D.W., Seo, J., Switzer, K.C., Fan, Y.Y., McMurray, D.N., Lupton, J.R., et al. n − 3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J. Nutr. Biochem. 15 (2004), 700–706.
16. [16] Nakamura, M.T., Cheon, Y., Li, Y., Nara, T.Y., Mechanisms of regulation of gene expression by fatty acids. Lipids 39 (2004), 1077–1083.
17. [17] Shaikh, S.R., Edidin, M., Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am. J. Clin. Nutr. 84 (2006), 1277–1289.
18. [18] Turk, H.F., Chapkin, R.S., Membrane lipid raft organization is uniquely modified by n − 3 polyunsaturated fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 88 (2013), 43–47.
19. [19] Weaver, K.L., Ivester, P., Seeds, M., Case, L.D., Arm, J.P., Chilton, F.H., Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J. Biol. Chem. 284 (2009), 15400–15407.
20. [20] Georgiadi, A., Boekschoten, M.V., Muller, M., Kersten, S., Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart. Physiol. Genomics 44 (2012), 352–361.
21. [21] World Health Organisation, Population nutrient intake goals for preventing diet-related chronic diseases. http://www.who.int/nutrition/topics/5_population_nutrient/en/index13.html (accessed 06/11/2014).
22. [22] Marine Conservation Society Feed Event, http://www.mcsuk.org/what_we_do/Fishing+for+our+future/Aquaculture+-+what+we+do/Feed+event (accessed 06/11/2014).
23. [23] Roberts, C., Feeding the world on fish. http://www.fhf.org.uk/meetings/meet_2010/2010-03-16_roberts.pdf (accessed 06/11/2014).
24. [24] Ministry of Agriculture Fisheries and Food, Dietary Intake of Iodine and Fatty Acids. Food Information Surveillance Sheet, 1997, Ministry of Agriculture, Fisheries and Food, London, 127.
25. [25] Hulshof, K.F., van Erp-Baart, M.A., Anttolainen, M., Becker, W., Church, S.M., Couet, C., et al. Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur. J. Clin. Nutr. 53 (1999), 143–157.
26. [26] Ollis, T.E., Meyer, B.J., Howe, P.R., Australian food sources and intakes of omega-6 and omega-3 polyunsaturated fatty acids. Ann. Nutr. Metab. 43 (1999), 346–355.
27. [27] Kris-Etherton, P.M., Taylor, D.S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., et al. Polyunsaturated fatty acids in the food chain in the United States. Am. J. Clin. Nutr. 71 (2000), 179S–188S.
28. [28] Innis, S.M., Elias, S.L., Intakes of essential n − 6 and n − 3 polyunsaturated fatty acids among pregnant Canadian women. Am. J. Clin. Nutr. 77 (2003), 473–478.
29. [29] EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J, 8, 2010, 1461.
30. [30] Burdge, G.C., Jones, A.E., Wootton, S.A., Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br. J. Nutr. 88 (2002), 355–363.
31. [31] Burdge, G.C., Wootton, S.A., Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88 (2002), 411–420.
32. [32] Goyens, P.L., Spilker, M.E., Zock, P.L., Katan, M.B., Mensink, R.P., Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am. J. Clin. Nutr. 84 (2006), 44–53.
33. [33] Vinton, N.E., Heckenlively, J.R., Laidlaw, S.A., Martin, D.A., Foxman, S.R., Ament, M.E., et al. Visual function in patients undergoing long-term total parenteral nutrition. Am. J. Clin. Nutr. 52 (1990), 895–902.
34. [34] Sinclair, A.J., Attar-Bashi, N.M., Li, D., What is the role of alpha-linolenic acid for mammals?. Lipids 37 (2002), 1113–1123.
35. [35] Astorg, P., Arnault, N., Czernichow, S., Noisette, N., Galan, P., Hercberg, S., Dietary intakes and food sources of n − 6 and n − 3 PUFA in French adult men and women. Lipids 39 (2004), 527–535.
36. [36] Jeffrey, B.G., Weisinger, H.S., Neuringer, M., Mitchell, D.C., The role of docosahexaenoic acid in retinal function. Lipids 36 (2001), 859–871.
37. [37] Mitchell, D.C., Niu, S.L., Litman, B.J., Enhancement of G protein-coupled signaling by DHA phospholipids. Lipids 38 (2003), 437–443.
38. [38] Surette, M.E., Edens, M., Chilton, F.H., Tramposch, K.M., Dietary echium oil increases plasma and neutrophil long-chain (n − 3) fatty acids and lowers serum triacylglycerols in hypertriglyceridemic humans. J. Nutr. 134 (2004), 1406–1411.
39. [39] Berti, M., Johnson, B.L., Dash, S., Fisher, S., Wilckens, R., Hevia, F., Echium: A source of stearidonic acid adapted to the Northern Great Plains in the US. Issues in new crops and new uses, 2007.
40. [40] Bioriginal, Echium oil. http://www.bioriginal.com/learning-center/omega-ingredients/plant-sourced/echium-oil-eu/ (accessed 17/11/2014).
41. [41] Ursin, V.M., Modification of plant lipids for human health: development of functional land-based omega-3 fatty acids. J. Nutr. 133 (2003), 4271–4274.
42. [42] Burdge, G.C., Calder, P.C., Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. Nutr. Res. Rev. 19 (2006), 26–52.
43. [43] British Nutrition Foundation, N − 3 Fatty Acids and Health - Briefing Paper. 1999, British Nutrition Foundation, London.
44. [44] Papanikolaou, Y., Brooks, J., Reider, C., Fulgoni, V.L. III, U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003–2008. Nutr. J., 13, 2014, 31.
45. [45] Guil-Guerrero, J.L., Stearidonic acid (18:4n − 3): Metabolism, nutritional importance, medical uses and natural sources. Eur. J. Lipid Sci. Technol. 109 (2007), 1226–1236.
46. [46] Deckelbaum, R.J., Torrejon, C., The omega-3 fatty acid nutritional landscape: health benefits and sources. J. Nutr. 142 (2012), 587S–591S.
47. [47] Harris, W.S., Stearidonic acid-enhanced soybean oil: a plant-based source of (n − 3) fatty acids for foods. J. Nutr. 142 (2012), 600S–604S.
48. [48] Bentley, S., Corn gromwell: a new oil crop for UK farmers, containing stearidonic acid (SDA), an omage-3 fatty acid from plants with the health benefit of fish oils. http://www.niab.com/pages/id/319/Corn_Gromwell (accessed 04/12/2014).
49. [49] Emken, E.A., Adlof, R.O., Gulley, R.M., Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta 1213 (1994), 277–288.
50. [50] Saunders, D.R., Sillery, J.K., Absorption of triglyceride by human small intestine: dose-response relationships. Am. J. Clin. Nutr. 48 (1988), 988–991.
51. [51] Andersen, L.F., Solvoll, K., Johansson, L.R., Salminen, I., Aro, A., Drevon, C.A., Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am. J. Epidemiol. 150 (1999), 75–87.
52. [52] Geerling, B.J., v Houwelingen, A.C., Badart-Smook, A., Stockbrugger, R.W., Brummer, R.J., Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am. J. Gastroenterol. 94 (1999), 410–417.
53. [53] Heath, R.B., Karpe, F., Milne, R.W., Burdge, G.C., Wootton, S.A., Frayn, K.N., Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period. J. Lipid Res. 44 (2003), 2065–2072.
54. [54] McCloy, U., Ryan, M.A., Pencharz, P.B., Ross, R.J., Cunnane, S.C., A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women. J. Lipid Res. 45 (2004), 474–485.
55. [55] Nettleton, J.A., Omega-3 fatty acids: comparison of plant and seafood sources in human nutrition. J. Am. Diet. Assoc. 91 (1991), 331–337.
56. [56] Burdge, G.C., Finnegan, Y.E., Minihane, A.M., Williams, C.M., Wootton, S.A., Effect of altered dietary n − 3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards beta-oxidation in older men. Br. J. Nutr. 90 (2003), 311–321.
57. [57] Vermunt, S.H., Mensink, R.P., Simonis, M.M., Hornstra, G., Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid. Lipids 35 (2000), 137–142.
58. [58] Burdge, G.C., Wootton, S.A., Conversion of α-linolenic acid to palmitic, palmitoleic, stearic and oleic acids in men and women. Prostaglandins Leukot. Essent. Fat. Acids 69 (2003), 283–290.
59. [59] Nakamura, M.T., Nara, T.Y., Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 24 (2004), 345–376.
60. [60] Agbaga, M.P., Mandal, M.N., Anderson, R.E., Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein. J. Lipid Res. 51 (2010), 1624–1642.
61. [61] Sassa, T., Kihara, A., Metabolism of very long-chain fatty acids: genes and pathophysiology. Biomol. Ther. (Seoul) 22 (2014), 83–92.
62. [62] Bernert, J.T. Jr., Sprecher, H., Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids. Biochim. Biophys. Acta 398 (1975), 354–363.
63. [63] Sprecher, H., Chen, Q., Yin, F.Q., Regulation of the biosynthesis of 22:5n − 6 and 22:6n − 3: a complex intracellular process. Lipids 34 (1999), S153–S156.
64. [64] Hrelia, S., Celadon, M., Rossi, C.A., Biagi, P.L., Bordoni, A., Delta-6-desaturation of linoleic and alpha-linolenic acids in aged rats: a kinetic analysis. Biochem. Int. 22 (1990), 659–667.
65. [65] Williard, D.E., Nwankwo, J.O., Kaduce, T.L., Harmon, S.D., Irons, M., Moser, H.W., et al. Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts. J. Lipid Res. 42 (2001), 501–508.
66. [66] D'Andrea, S., Guillou, H., Jan, S., Catheline, D., Thibault, J.N., Bouriel, M., et al. The same rat Delta6-desaturase not only acts on 18- but also on 24-carbon fatty acids in very-long-chain polyunsaturated fatty acid biosynthesis. Biochem. J. 364 (2002), 49–55.
67. [67] Sprecher, H., Metabolism of highly unsaturated n − 3 and n − 6 fatty acids. Biochim. Biophys. Acta 1486 (2000), 219–231.
68. [68] Voss, A., Reinhart, M., Sankarappa, S., Sprecher, H., The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J. Biol. Chem. 266 (1991), 19995–20000.
69. [69] Gregory, M.K., Gibson, R.A., Cook-Johnson, R.J., Cleland, L.G., James, M.J., Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One, 6, 2011, e29662.
70. [70] Whelan, J., Gouffon, J., Zhao, Y., Effects of dietary stearidonic acid on biomarkers of lipid metabolism. J. Nutr. 142 (2012), 630S–634S.
71. [71] Cho, H.P., Nakamura, M., Clarke, S.D., Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J. Biol. Chem. 274 (1999), 37335–37339.
72. [72] Matsuzaka, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Yoshikawa, T., Hasty, A.H., et al. Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J. Lipid Res. 43 (2002), 107–114.
73. [73] Lattka, E., Illig, T., Heinrich, J., Koletzko, B., Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?. Clin. Nutr. 29 (2010), 277–287.
74. [74] Schaeffer, L., Gohlke, H., Muller, M., Heid, I.M., Palmer, L.J., Kompauer, I., et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet. 15 (2006), 1745–1756.
75. [75] Lattka, E., Eggers, S., Moeller, G., Heim, K., Weber, M., Mehta, D., et al. A common FADS2 promoter polymorphism increases promoter activity and facilitates binding of transcription factor ELK1. J. Lipid Res. 51 (2010), 182–191.
76. [76] Reardon, H.T., Zhang, J., Kothapalli, K.S., Kim, A.J., Park, W.J., Brenna, J.T., Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin. Prostaglandins Leukot. Essent. Fat. Acids 87 (2012), 25–33.
77. [77] Alsaleh, A., Maniou, Z., Lewis, F.J., Hall, W.L., Sanders, T.A., O'Dell, S.D., ELOVL2 gene polymorphisms are associated with increases in plasma eicosapentaenoic and docosahexaenoic acid proportions after fish oil supplement. Genes Nutr., 9, 2014, 362.
78. [78] Tanaka, T., Shen, J., Abecasis, G.R., Kisialiou, A., Ordovas, J.M., Guralnik, J.M., et al. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet., 5, 2009, e1000338.
79. [79] Devlin, A.M., Singh, R., Wade, R.E., Innis, S.M., Bottiglieri, T., Lentz, S.R., Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J. Biol. Chem. 282 (2007), 37082–37090.
80. [80] Niculescu, M.D., Lupu, D.S., Craciunescu, C.N., Maternal alpha-linolenic acid availability during gestation and lactation alters the postnatal hippocampal development in the mouse offspring. Int. J. Dev. Neurosci. 29 (2011), 795–802.
81. [81] Hoile, S.P., Irvine, N.A., Kelsall, C.J., Sibbons, C., Feunteun, A., Collister, A., et al. Maternal fat intake in rats alters 20:4n − 6 and 22:6n − 3 status and the epigenetic regulation of Fads2 in offspring liver. J. Nutr. Biochem. 24 (2013), 1213–1220.
82. [82] Kelsall, C.J., Hoile, S.P., Irvine, N.A., Masoodi, M., Torrens, C., Lillycrop, K.A., et al. Vascular dysfunction induced in offspring by maternal dietary fat involves altered arterial polyunsaturated fatty acid biosynthesis. PLoS One, 7, 2012, e34492.
83. [83] Howard, T.D., Mathias, R.A., Seeds, M.C., Herrington, D.M., Hixson, J.E., Shimmin, L.C., et al. DNA methylation in an enhancer region of the FADS cluster is associated with FADS activity in human liver. PLoS One, 9, 2014, e97510.
84. [84] Cheatham, C.L., Lupu, D.S., Niculescu, M.D., Genetic and epigenetic transgenerational implications related to omega-3 fatty acids. Part II: maternal FADS2 rs174575 genotype and DNA methylation predict toddler cognitive performance. Nutr. Res. 35 (2015), 948–955.
85. [85] Hoile, S.P., Clarke-Harris, R., Huang, R.C., Calder, P.C., Mori, T.A., Beilin, L.J., et al. Supplementation with N − 3 long-chain polyunsaturated fatty acids or olive oil in men and women with renal disease induces differential changes in the DNA methylation of FADS2 and ELOVL5 in peripheral blood mononuclear cells. PLoS One, 9, 2014, e109896.
86. [86] Malerba, G., Schaeffer, L., Xumerle, L., Klopp, N., Trabetti, E., Biscuola, M., et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 43 (2008), 289–299.
87. [87] Xie, L., Innis, S.M., Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n − 6) and (n − 3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 138 (2008), 2222–2228.
88. [88] Rzehak, P., Thijs, C., Standl, M., Mommers, M., Glaser, C., Jansen, E., et al. Variants of the FADS1 FADS2 gene cluster, blood levels of polyunsaturated fatty acids and eczema in children within the first 2 years of life. PLoS One, 5, 2010, e13261.
89. [89] Molto-Puigmarti, C., Plat, J., Mensink, R.P., Muller, A., Jansen, E., Zeegers, M.P., et al. FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk. Am. J. Clin. Nutr. 91 (2010), 1368–1376.
90. [90] Lattka, E., Rzehak, P., Szabo, E., Jakobik, V., Weck, M., Weyermann, M., et al. Genetic variants in the FADS gene cluster are associated with arachidonic acid concentrations of human breast milk at 1.5 and 6 mo postpartum and influence the course of milk dodecanoic, tetracosenoic, and trans-9-octadecenoic acid concentrations over the duration of lactation. Am. J. Clin. Nutr. 93 (2011), 382–391.
91. [91] Morales, E., Bustamante, M., Gonzalez, J.R., Guxens, M., Torrent, M., Mendez, M., et al. Genetic variants of the FADS gene cluster and ELOVL gene family, colostrums LC-PUFA levels, breastfeeding, and child cognition. PLoS One, 6, 2011, e17181.
92. [92] Al-Hilal, M., Alsaleh, A., Maniou, Z., Lewis, F.J., Hall, W.L., Sanders, T.A., et al. Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement. J. Lipid Res. 54 (2013), 542–551.
93. [93] Abdelmagid, S.A., Clarke, S.E., Roke, K., Nielsen, D.E., Badawi, A., El-Sohemy, A., et al. Ethnicity, sex, FADS genetic variation, and hormonal contraceptive use influence delta-5- and delta-6-desaturase indices and plasma docosahexaenoic acid concentration in young Canadian adults: a cross-sectional study. Nutr. Metab. (Lond.), 12, 2015, 14.
94. [94] Haghighi, F., Galfalvy, H., Chen, S., Huang, Y.Y., Cooper, T.B., Burke, A.K., et al. DNA methylation perturbations in genes involved in polyunsaturated Fatty Acid biosynthesis associated with depression and suicide risk. Front. Neurol., 6, 2015, 92.
95. [95] Moore, S.A., Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J. Mol. Neurosci. 16 (2001), 195–200.
96. [96] Monk, J.M., Liddle, D.M., Cohen, D.J., Tsang, D.H., Hillyer, L.M., Abdelmagid, S.A., et al. The delta 6 desaturase knock out mouse reveals that immunomodulatory effects of essential n − 6 and n − 3 polyunsaturated fatty acids are both independent of and dependent upon conversion. J. Nutr. Biochem. 32 (2016), 29–38.
97. [97] James, M.J., Ursin, V.M., Cleland, L.G., Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n − 3 fatty acids. Am. J. Clin. Nutr. 77 (2003), 1140–1145.
98. [98] Lemke, S.L., Vicini, J.L., Su, H., Goldstein, D.A., Nemeth, M.A., Krul, E.S., et al. Dietary intake of stearidonic acid-enriched soybean oil increases the omega-3 index: randomized, double-blind clinical study of efficacy and safety. Am. J. Clin. Nutr. 92 (2010), 766–775.
99. [99] Miles, E.A., Banerjee, T., Dooper, M.M., M'Rabet, L., Graus, Y.M., Calder, P.C., The influence of different combinations of gamma-linolenic acid, stearidonic acid and EPA on immune function in healthy young male subjects. Br. J. Nutr. 91 (2004), 893–903.
100. [100] Krul, E.S., Lemke, S.L., Mukherjea, R., Taylor, M.L., Goldstein, D.A., Su, H., et al. Effects of duration of treatment and dosage of eicosapentaenoic acid and stearidonic acid on red blood cell eicosapentaenoic acid content. Prostaglandins Leukot. Essent. Fat. Acids 86 (2012), 51–59.
101. [101] Arterburn, L.M., Hall, E.B., Oken, H., Distribution, interconversion, and dose response of n − 3 fatty acids in humans. Am. J. Clin. Nutr. 83 (2006), 1467S–1476S.
102. [102] Morris D. Metabolism of Alpha-linolenic acid. New Flax Facts http://flaxcouncil.ca/wp-content/uploads/2015/03/Flax_FSht_FoodSourc08_R2.pdf.
103. [103] Harris, W.S., The omega-3 index as a risk factor for coronary heart disease. Am. J. Clin. Nutr. 87 (2008), 1997S–2002S.
104. [104] Lemke, S.L., Maki, K.C., Hughes, G., Taylor, M.L., Krul, E.S., Goldstein, D.A., et al. Consumption of stearidonic acid-rich oil in foods increases red blood cell eicosapentaenoic acid. J. Acad. Nutr. Diet. 113 (2013), 1044–1056.
105. [105] Pieters, D.J., Mensink, R.P., Effects of stearidonic acid on serum triacylglycerol concentrations in overweight and obese subjects: a randomized controlled trial. Eur. J. Clin. Nutr. 69 (2014), 121–126.
106. [106] Dittrich, M., Jahreis, G., Bothor, K., Drechsel, C., Kiehntopf, M., Bluher, M., et al. Benefits of foods supplemented with vegetable oils rich in alpha-linolenic, stearidonic or docosahexaenoic acid in hypertriglyceridemic subjects: a double-blind, randomized, controlled trail. Eur. J. Nutr. 54 (2014), 881–893.
107. [107] Kuhnt, K., Fuhrmann, C., Kohler, M., Kiehntopf, M., Jahreis, G., Dietary echium oil increases long-chain n − 3 PUFAs, including docosapentaenoic acid, in blood fractions and alters biochemical markers for cardiovascular disease independently of age, sex, and metabolic syndrome. J. Nutr. 144 (2014), 447–460.
108. [108] Emken, E.A., Adlof, R.O., Duval, S.M., Nelson, G.J., Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids 34 (1999), 785–791.
109. [109] Salem, N. Jr., Pawlosky, R., Wegher, B., Hibbeln, J., In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukot. Essent. Fat. Acids 60 (1999), 407–410.
110. [110] Pawlosky, R.J., Hibbeln, J.R., Novotny, J.A., Salem, N. Jr., Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res. 42 (2001), 1257–1265.
111. [111] Hussein, N., Ah-Sing, E., Wilkinson, P., Leach, C., Griffin, B.A., Millward, D.J., Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J. Lipid Res. 46 (2005), 269–280.
112. [112] Goyens, P.L., Spilker, M.E., Zock, P.L., Katan, M.B., Mensink, R.P., Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J. Lipid Res. 46 (2005), 1474–1483.
113. [113] Burdge, G.C., Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fat. Acids 75 (2006), 161–168.
114. [114] Emken, E.A., Stable isotope approaches, applications, and issues related to polyunsaturated fatty acid metabolism studies. Lipids 36 (2001), 965–973.
115. [115] Pawlosky, R.J., Hibbeln, J.R., Lin, Y., Goodson, S., Riggs, P., Sebring, N., et al. Effects of beef- and fish-based diets on the kinetics of n − 3 fatty acid metabolism in human subjects. Am. J. Clin. Nutr. 77 (2003), 565–572.
116. [116] Pawlosky, R., Hibbeln, J., Lin, Y., Salem, N. Jr., n − 3 fatty acid metabolism in women. Br. J. Nutr. 90 (2003), 993–994.
117. [117] Tang, C., Cho, H.P., Nakamura, M.T., Clarke, S.D., Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element. J. Lipid Res. 44 (2003), 686–695.
118. [118] Lin, Y.H., Llanos, A., Mena, P., Uauy, R., Salem, N. Jr., Pawlosky, R.J., Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n − 3 in newborn term infants. Am. J. Clin. Nutr. 92 (2010), 284–293.
119. [119] Bemelmans, W.J., Broer, J., Feskens, E.J., Smit, A.J., Muskiet, F.A., Lefrandt, J.D., et al. Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am. J. Clin. Nutr. 75 (2002), 221–227.
120. [120] Chan, J.K., Bruce, V.M., McDonald, B.E., Dietary alpha-linolenic acid is as effective as oleic acid and linoleic acid in lowering blood cholesterol in normolipidemic men. Am. J. Clin. Nutr. 53 (1991), 1230–1234.
121. [121] Cunnane, S.C., Hamadeh, M.J., Liede, A.C., Thompson, L.U., Wolever, T.M., Jenkins, D.J., Nutritional attributes of traditional flaxseed in healthy young adults. Am. J. Clin. Nutr. 61 (1995), 62–68.
122. [122] de Groot, R.H., Hornstra, G., van Houwelingen, A.C., Roumen, F., Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am. J. Clin. Nutr. 79 (2004), 251–260.
123. [123] Ezaki, O., Takahashi, M., Shigematsu, T., Shimamura, K., Kimura, J., Ezaki, H., et al. Long-term effects of dietary alpha-linolenic acid from perilla oil on serum fatty acids composition and on the risk factors of coronary heart disease in Japanese elderly subjects. J. Nutr. Sci. Vitaminol. (Tokyo) 45 (1999), 759–772.
124. [124] Finnegan, Y.E., Minihane, A.M., Leigh-Firbank, E.C., Kew, S., Meijer, G.W., Muggli, R., et al. Plant- and marine-derived n − 3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 77 (2003), 783–795.
125. [125] Francois, C.A., Connor, S.L., Bolewicz, L.C., Connor, W.E., Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. Am. J. Clin. Nutr. 77 (2003), 226–233.
126. [126] Freese, R., Mutanen, M., Valsta, L.M., Salminen, I., Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb. Haemost. 71 (1994), 73–77.
127. [127] Harper, C.R., Edwards, M.J., DeFilippis, A.P., Jacobson, T.A., Flaxseed oil increases the plasma concentrations of cardioprotective (n − 3) fatty acids in humans. J. Nutr. 136 (2006), 83–87.
128. [128] Kelley, D.S., Nelson, G.J., Love, J.E., Branch, L.B., Taylor, P.C., Schmidt, P.C., et al. Dietary alpha-linolenic acid alters tissue fatty acid composition, but not blood lipids, lipoproteins or coagulation status in humans. Lipids 28 (1993), 533–537.
129. [129] Li, D., Sinclair, A., Wilson, A., Nakkote, S., Kelly, F., Abedin, L., et al. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am. J. Clin. Nutr. 69 (1999), 872–882.
130. [130] Mantzioris, E., James, M.J., Gibson, R.A., Cleland, L.G., Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am. J. Clin. Nutr. 59 (1994), 1304–1309.
131. [131] Sanders, T.A., Younger, K.M., The effect of dietary supplements of omega 3 polyunsaturated fatty acids on the fatty acid composition of platelets and plasma choline phosphoglycerides. Br. J. Nutr. 45 (1981), 613–616.
132. [132] Wallace, F.A., Miles, E.A., Calder, P.C., Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br. J. Nutr. 89 (2003), 679–689.
133. [133] Zhao, G., Etherton, T.D., Martin, K.R., Gillies, P.J., West, S.G., Kris-Etherton, P.M., Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. Am. J. Clin. Nutr. 85 (2007), 385–391.
134. [134] Zhao, G., Etherton, T.D., Martin, K.R., West, S.G., Gillies, P.J., Kris-Etherton, P.M., Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134 (2004), 2991–2997.
135. [135] Austria, J.A., Richard, M.N., Chahine, M.N., Edel, A.L., Malcolmson, L.J., Dupasquier, C.M., et al. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J. Am. Coll. Nutr. 27 (2008), 214–221.
136. [136] Barden, A.E., Croft, K.D., Durand, T., Guy, A., Mueller, M.J., Mori, T.A., Flaxseed oil supplementation increases plasma F1-phytoprostanes in healthy men. J. Nutr. 139 (2009), 1890–1895.
137. [137] Bloedon, L.T., Balikai, S., Chittams, J., Cunnane, S.C., Berlin, J.A., Rader, D.J., et al. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J. Am. Coll. Nutr. 27 (2008), 65–74.
138. [138] Chiang, Y.L., Haddad, E., Rajaram, S., Shavlik, D., Sabate, J., The effect of dietary walnuts compared to fatty fish on eicosanoids, cytokines, soluble endothelial adhesion molecules and lymphocyte subsets: a randomized, controlled crossover trial. Prostaglandins Leukot. Essent. Fat. Acids 87 (2012), 111–117.
139. [139] Dodin, S., Cunnane, S.C., Masse, B., Lemay, A., Jacques, H., Asselin, G., et al. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 24 (2008), 23–30.
140. [140] Egert, S., Kannenberg, F., Somoza, V., Erbersdobler, H.F., Wahrburg, U., Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J. Nutr. 139 (2009), 861–868.
141. [141] Geleijnse, J.M., Giltay, E.J., Kromhout, D., Effects of n − 3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 8 (2012), 278–287.
142. [142] Hutchins, A.M., Brown, B.D., Cunnane, S.C., Domitrovich, S.G., Adams, E.R., Bobowiec, C.E., Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr. Res. 33 (2013), 367–375.
143. [143] Kaul, N., Kreml, R., Austria, J.A., Richard, M.N., Edel, A.L., Dibrov, E., et al. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J. Am. Coll. Nutr. 27 (2008), 51–58.
144. [144] Patenaude, A., Rodriguez-Leyva, D., Edel, A.L., Dibrov, E., Dupasquier, C.M., Austria, J.A., et al. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur. J. Clin. Nutr. 63 (2009), 1123–1129.
145. [145] Pintus, S., Murru, E., Carta, G., Cordeddu, L., Batetta, B., Accossu, S., et al. Sheep cheese naturally enriched in alpha-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects. Br. J. Nutr. 109 (2013), 1453–1462.
146. [146] Ristic-Medic, D., Perunicic-Pekovic, G., Rasic-Milutinovic, Z., Takic, M., Popovic, T., Arsic, A., et al. Effects of dietary milled seed mixture on fatty acid status and inflammatory markers in patients on hemodialysis. Sci. World J., 2014, 2014, 563576.
147. [147] Rodriguez-Leyva, D., Weighell, W., Edel, A.L., LaVallee, R., Dibrov, E., Pinneker, R., et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 62 (2013), 1081–1089.
148. [148] Taylor, C.G., Noto, A.D., Stringer, D.M., Froese, S., Malcolmson, L., Dietary milled flaxseed and flaxseed oil improve N − 3 fatty acid status and do not affect glycemic control in individuals with well-controlled type 2 diabetes. J. Am. Coll. Nutr. 29 (2010), 72–80.
149. [149] West, S.G., Krick, A.L., Klein, L.C., Zhao, G., Wojtowicz, T.F., McGuiness, M., et al. Effects of diets high in walnuts and flax oil on hemodynamic responses to stress and vascular endothelial function. J. Am. Coll. Nutr. 29 (2010), 595–603.
150. [150] Allman, M.A., Pena, M.M., Pang, D., Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur. J. Clin. Nutr. 49 (1995), 169–178.
151. [151] Allman-Farinelli, M.A., Hall, D., Kingham, K., Pang, D., Petocz, P., Favaloro, E.J., Comparison of the effects of two low fat diets with different alpha-linolenic:linoleic acid ratios on coagulation and fibrinolysis. Atherosclerosis 142 (1999), 159–168.
152. [152] Caughey, G.E., Mantzioris, E., Gibson, R.A., Cleland, L.G., James, M.J., The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n − 3 fatty acids from vegetable oil or fish oil. Am. J. Clin. Nutr. 63 (1996), 116–122.
153. [153] Healy, D.A., Wallace, F.A., Miles, E.A., Calder, P.C., Newsholm, P., Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35 (2000), 763–768.
154. [154] Kew, S., Banerjee, T., Minihane, A.M., Finnegan, Y.E., Muggli, R., Albers, R., et al. Lack of effect of foods enriched with plant- or marine-derived n − 3 fatty acids on human immune function. Am. J. Clin. Nutr. 77 (2003), 1287–1295.
155. [155] Kwon, J.S., Snook, J.T., Wardlaw, G.M., Hwang, D.H., Effects of diets high in saturated fatty acids, canola oil, or safflower oil on platelet function, thromboxane B2 formation, and fatty acid composition of platelet phospholipids. Am. J. Clin. Nutr. 54 (1991), 351–358.
156. [156] Mutanen, M., Freese, R., Valsta, L.M., Ahola, I., Ahlstrom, A., Rapeseed oil and sunflower oil diets enhance platelet in vitro aggregation and thromboxane production in healthy men when compared with milk fat or habitual diets. Thromb. Haemost. 67 (1992), 352–356.
157. [157] Nelson, T.L., Stevens, J.R., Hickey, M.S., Inflammatory markers are not altered by an eight week dietary alpha-linolenic acid intervention in healthy abdominally obese adult males and females. Cytokine 38 (2007), 101–106.
158. [158] Sanders, T.A., Roshanai, F., The influence of different types of omega 3 polyunsaturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin. Sci. (Lond.) 64 (1983), 91–99.
159. [159] Weaver, B.J., Corner, E.J., Bruce, V.M., McDonald, B.E., Holub, B.J., Dietary canola oil: effect on the accumulation of eicosapentaenoic acid in the alkenylacyl fraction of human platelet ethanolamine phosphoglyceride. Am. J. Clin. Nutr. 51 (1990), 594–598.
160. [160] Wilkinson, P., Leach, C., Ah-Sing, E.E., Hussain, N., Miller, G.J., Millward, D.J., et al. Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis 181 (2005), 115–124.
161. [161] Dewell, A., Marvasti, F.F., Harris, W.S., Tsao, P., Gardner, C.D., Low- and high-dose plant and marine (n − 3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J. Nutr. 141 (2011), 2166–2171.
162. [162] Egert, S., Lindenmeier, M., Harnack, K., Krome, K., Erbersdobler, H.F., Wahrburg, U., et al. Margarines fortified with alpha-linolenic acid, eicosapentaenoic acid, or docosahexaenoic acid alter the fatty acid composition of erythrocytes but do not affect the antioxidant status of healthy adults. J. Nutr. 142 (2012), 1638–1644.
163. [163] Kontogianni, M.D., Vlassopoulos, A., Gatzieva, A., Farmaki, A.E., Katsiougiannis, S., Panagiotakos, D.B., et al. Flaxseed oil does not affect inflammatory markers and lipid profile compared to olive oil, in young, healthy, normal weight adults. Metabolism 62 (2013), 686–693.
164. [164] Rajaram, S., Haddad, E.H., Mejia, A., Sabate, J., Walnuts and fatty fish influence different serum lipid fractions in normal to mildly hyperlipidemic individuals: a randomized controlled study. Am. J. Clin. Nutr. 89 (2009), 1657S–1663S.
165. [165] Arm, J.P., Boyce, J.A., Wang, L., Chhay, H., Zahid, M., Patil, V., et al. Impact of botanical oils on polyunsaturated fatty acid metabolism and leukotriene generation in mild asthmatics. Lipids Health Dis., 12, 2013, 141.
166. [166] Harris, W.S., Lemke, S.L., Hansen, S.N., Goldstein, D.A., DiRienzo, M.A., Su, H., et al. Stearidonic acid-enriched soybean oil increased the omega-3 index, an emerging cardiovascular risk marker. Lipids 43 (2008), 805–811.
167. [167] Miles, E.A., Banerjee, T., Calder, P.C., The influence of different combinations of gamma-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers. Prostaglandins Leukot. Essent. Fat. Acids 70 (2004), 529–538.
168. [168] Han, S.N., Lichtenstein, A.H., Ausman, L.M., Meydani, S.N., Novel soybean oils differing in fatty acid composition alter immune functions of moderately hypercholesterolemic older adults. J. Nutr. 142 (2012), 2182–2187.
169. [169] Chan, J.K., McDonald, B.E., Gerrard, J.M., Bruce, V.M., Weaver, B.J., Holub, B.J., Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenesis. Lipids 28 (1993), 811–817.
170. [170] Schwartz, J., Dube, K., Sichert-Hellert, W., Kannenberg, F., Kunz, C., Kalhoff, H., et al. Modification of dietary polyunsaturated fatty acids via complementary food enhances n − 3 long-chain polyunsaturated fatty acid synthesis in healthy infants: a double blinded randomised controlled trial. Arch. Dis. Child. 94 (2009), 876–882.
171. [171] Gracious, B.L., Chirieac, M.C., Costescu, S., Finucane, T.L., Youngstrom, E.A., Hibbeln, J.R., Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord. 12 (2010), 142–154.
172. [172] Sauerwald, T.U., Hachey, D.L., Jensen, C.L., Chen, H., Anderson, R.E., Heird, W.C., Effect of dietary alpha-linolenic acid intake on incorporation of docosahexaenoic and arachidonic acids into plasma phospholipids of term infants. Lipids 31 (1996), S131–S135.
173. [173] Clark, K.J., Makrides, M., Neumann, M.A., Gibson, R.A., Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J. Pediatr. 120 (1992), S151–S158.
174. [174] Jensen, C.L., Chen, H., Fraley, J.K., Anderson, R.E., Heird, W.C., Biochemical effects of dietary linoleic/alpha-linolenic acid ratio in term infants. Lipids 31 (1996), 107–113.
175. [175] Brenna, J.T., Efficiency of conversion of alpha-linolenic acid to long chain n − 3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002), 127–132.
176. [176] Lohner, S., Fekete, K., Marosvolgyi, T., Decsi, T., Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann. Nutr. Metab. 62 (2013), 98–112.
177. [177] Childs, C.E., Kew, S., Finnegan, Y.E., Minihane, A.M., Leigh-Firbank, E.C., Williams, C.M., et al. Increased dietary alpha-linolenic acid has sex-specific effects upon eicosapentaenoic acid status in humans: re-examination of data from a randomised, placebo-controlled, parallel study. Nutr. J., 13, 2014, 113.
178. [178] Ottosson, U.B., Lagrelius, A., Rosing, U., von Schoultz, B., Relative fatty acid composition of lecithin during postmenopausal replacement therapy--a comparison between ethinyl estradiol and estradiol valerate. Gynecol. Obstet. Investig. 18 (1984), 296–302.
179. [179] Giltay, E.J., Gooren, L.J., Toorians, A.W., Katan, M.B., Zock, P.L., Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am. J. Clin. Nutr. 80 (2004), 1167–1174.
180. [180] Kris-Etherton, P.M., Harris, W.S., Appel, L.J., American Heart Association. Nutrition C. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002), 2747–2757.
181. [181] He, K., Rimm, E.B., Merchant, A., Rosner, B.A., Stampfer, M.J., Willett, W.C., et al. Fish consumption and risk of stroke in men. JAMA 288 (2002), 3130–3136.
182. [182] Shoda, R., Matsueda, K., Yamato, S., Umeda, N., Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n − 6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am. J. Clin. Nutr. 63 (1996), 741–745.
183. [183] Pischon, T., Hankinson, S.E., Hotamisligil, G.S., Rifai, N., Willett, W.C., Rimm, E.B., Habitual dietary intake of n − 3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 108 (2003), 155–160.
184. [184] Lopez-Garcia, E., Schulze, M.B., Fung, T.T., Meigs, J.B., Rifai, N., Manson, J.E., et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 80 (2004), 1029–1035.
185. [185] Rangel-Huerta, O.D., Aguilera, C.M., Mesa, M.D., Gil, A., Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br. J. Nutr. 107 (2012), S159–S170.
186. [186] Harris, W.S., n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids 31 (1996), 243–252.
187. [187] Roche, H.M., Gibney, M.J., Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state. Lipids 34 (1999), S259–S265.
188. [188] Williams, C.M., Postprandial lipid metabolism: effects of dietary fatty acids. Proc. Nutr. Soc. 56 (1997), 679–692.
189. [189] Geleijnse, J.M., Giltay, E.J., Grobbee, D.E., Donders, A.R., Kok, F.J., Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20 (2002), 1493–1499.
190. [190] Harris, W.S., Connor, W.E., Goodnight, S.H. Jr., Dietary fish oils, plasma lipids and platelets in man. Prog. Lipid Res. 20 (1981), 75–79.
191. [191] von Schacky, C., Fischer, S., Weber, P.C., Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J. Clin. Invest. 76 (1985), 1626–1631.
192. [192] Miller, G.J., Dietary fatty acids and blood coagulation. Prostaglandins Leukot. Essent. Fat. Acids 57 (1997), 389–394.
193. [193] Christensen, J.H., Gustenhoff, P., Korup, E., Aaroe, J., Toft, E., Moller, J., et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 312 (1996), 677–678.
194. [194] Christensen, J.H., Skou, H.A., Fog, L., Hansen, V., Vesterlund, T., Dyerberg, J., et al. Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103 (2001), 651–657.
195. [195] Schrepf, R., Limmert, T., Claus Weber, P., Theisen, K., Sellmayer, A., Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 363 (2004), 1441–1442.
196. [196] Chin, J.P., Dart, A.M., How do fish oils affect vascular function?. Clin. Exp. Pharmacol. Physiol. 22 (1995), 71–81.
197. [197] McVeigh, G.E., Brennan, G.M., Cohn, J.N., Finkelstein, S.M., Hayes, R.J., Johnston, G.D., Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler. Thromb. 14 (1994), 1425–1429.
198. [198] Goode, G.K., Garcia, S., Heagerty, A.M., Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 96 (1997), 2802–2807.
199. [199] Tagawa, H., Shimokawa, H., Tagawa, T., Kuroiwa-Matsumoto, M., Hirooka, Y., Takeshita, A., Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease. J. Cardiovasc. Pharmacol. 33 (1999), 633–640.
200. [200] Calder, P.C., Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36 (2001), 1007–1024.
201. [201] Calder, P.C., Dietary modification of inflammation with lipids. Proc. Nutr. Soc. 61 (2002), 345–358.
202. [202] Calder, P.C., N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38 (2003), 343–352.
203. [203] Calder, P.C., Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33 (2005), 423–427.
204. [204] Calder, P.C., n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc. Nutr. Soc. 72 (2013), 326–336.
205. [205] Suzukawa, M., Abbey, M., Howe, P.R., Nestel, P.J., Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res. 36 (1995), 473–484.
206. [206] Sorensen, N.S., Marckmann, P., Hoy, C.E., van Duyvenvoorde, W., Princen, H.M., Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation. Am. J. Clin. Nutr. 68 (1998), 235–241.
207. [207] Baylin, A., Kabagambe, E.K., Ascherio, A., Spiegelman, D., Campos, H., Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation 107 (2003), 1586–1591.
208. [208] Campos, H., Baylin, A., Willett, W.C., Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 118 (2008), 339–345.
209. [209] Dolecek, T.A., Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc. Soc. Exp. Biol. Med. 200 (1992), 177–182.
210. [210] Hu, F.B., Stampfer, M.J., Manson, J.E., Rimm, E.B., Wolk, A., Colditz, G.A., et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am. J. Clin. Nutr. 69 (1999), 890–897.
211. [211] Ascherio, A., Rimm, E.B., Giovannucci, E.L., Spiegelman, D., Stampfer, M., Willett, W.C., Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313 (1996), 84–90.
212. [212] Djousse, L., Pankow, J.S., Eckfeldt, J.H., Folsom, A.R., Hopkins, P.N., Province, M.A., et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am. J. Clin. Nutr. 74 (2001), 612–619.
213. [213] Brouwer, I.A., Katan, M.B., Zock, P.L., Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J. Nutr. 134 (2004), 919–922.
214. [214] Pan, A., Chen, M., Chowdhury, R., Wu, J.H., Sun, Q., Campos, H., et al. alpha-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr. 96 (2012), 1262–1273.
215. [215] Wendland, E., Farmer, A., Glasziou, P., Neil, A., Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92 (2006), 166–169.
216. [216] Oomen, C.M., Ocke, M.C., Feskens, E.J., Kok, F.J., Kromhout, D., alpha-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am. J. Clin. Nutr. 74 (2001), 457–463.
217. [217] Simon, J.A., Fong, J., Bernert, J.T. Jr., Browner, W.S., Serum fatty acids and the risk of stroke. Stroke 26 (1995), 778–782.
218. [218] Vedtofte, M.S., Jakobsen, M.U., Lauritzen, L., Heitmann, B.L., Dietary alpha-linolenic acid, linoleic acid, and n-3 long-chain PUFA and risk of ischemic heart disease. Am. J. Clin. Nutr. 94 (2011), 1097–1103.
219. [219] Lemaitre, R.N., Sitlani, C., Song, X., King, I.B., McKnight, B., Spiegelman, D., et al. Circulating and dietary alpha-linolenic acid and incidence of congestive heart failure in older adults: the Cardiovascular Health Study. Am. J. Clin. Nutr. 96 (2012), 269–274.
220. [220] de Goede, J., Verschuren, W.M., Boer, J.M., Verberne, L.D., Kromhout, D., Geleijnse, J.M., N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis. PLoS One, 8, 2013, e59408.
221. [221] Harris, W.S., Poston, W.C., Haddock, C.K., Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (2007), 1–10.
222. [222] de Lorgeril, M., Renaud, S., Mamelle, N., Salen, P., Martin, J.L., Monjaud, I., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343 (1994), 1454–1459.
223. [223] de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Delaye, J., Mamelle, N., Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99 (1999), 779–785.
224. [224] Fleming, J.A., Kris-Etherton, P.M., The evidence for alpha-linolenic acid and cardiovascular disease benefits: comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv. Nutr. 5 (2014), 863S–876S.
225. [225] Kromhout, D., Giltay, E.J., Geleijnse, J.M., Alpha Omega Trial G. n-3 fatty acids and cardiovascular events after myocardial infarction. N. Engl. J. Med. 363 (2010), 2015–2026.
226. [226] Katan, M.B., Zock, P.L., Mensink, R.P., Dietary oils, serum lipoproteins, and coronary heart disease. Am. J. Clin. Nutr. 61 (1995), 1368S–1373S.
227. [227] Arjmandi, B.H., Khan, D.A., Juma, S., Drum, M.L., Venkatesh, S., Sohn, E., et al. Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr. Res. 18 (1998), 1203–1214.
228. [228] Freese, R., Mutanen, M., Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. Am. J. Clin. Nutr. 66 (1997), 591–598.
229. [229] Kestin, M., Clifton, P., Belling, G.B., Nestel, P.J., n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am. J. Clin. Nutr. 51 (1990), 1028–1034.
230. [230] Layne, K.S., Goh, Y.K., Jumpsen, J.A., Ryan, E.A., Chow, P., Clandinin, M.T., Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. J. Nutr. 126 (1996), 2130–2140.
231. [231] Nestel, P.J., Pomeroy, S.E., Sasahara, T., Yamashita, T., Liang, Y.L., Dart, A.M., et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler. Thromb. Vasc. Biol. 17 (1997), 1163–1170.
232. [232] Pang, D., Allman-Farinelli, M.A., Wong, T., Barnes, R., Kingham, K.M., Replacement of linoleic acid with alpha-linolenic acid does not alter blood lipids in normolipidaemic men. Br. J. Nutr. 80 (1998), 163–167.
233. [233] Singer, P., Berger, I., Wirth, M., Godicke, W., Jaeger, W., Voigt, S., Slow desaturation and elongation of linoleic and alpha-linolenic acids as a rationale of eicosapentaenoic acid-rich diet to lower blood pressure and serum lipids in normal, hypertensive and hyperlipemic subjects. Prostaglandins Leukot. Med. 24 (1986), 173–193.
234. [234] Finnegan, Y.E., Howarth, D., Minihane, A.M., Kew, S., Miller, G.J., Calder, P.C., et al. Plant and marine derived (n-3) polyunsaturated fatty acids do not affect blood coagulation and fibrinolytic factors in moderately hyperlipidemic humans. J. Nutr. 133 (2003), 2210–2213.
235. [235] Junker, R., Kratz, M., Neufeld, M., Erren, M., Nofer, J.R., Schulte, H., et al. Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system. Thromb. Haemost. 85 (2001), 280–286.
236. [236] Karvonen, H.M., Aro, A., Tapola, N.S., Salminen, I., Uusitupa, M.I., Sarkkinen, E.S., Effect of alpha-linolenic acid-rich Camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects. Metabolism 51 (2002), 1253–1260.
237. [237] Sodergren, E., Gustafsson, I.B., Basu, S., Nourooz-Zadeh, J., Nalsen, C., Turpeinen, A., et al. A diet containing rapeseed oil-based fats does not increase lipid peroxidation in humans when compared to a diet rich in saturated fatty acids. Eur. J. Clin. Nutr. 55 (2001), 922–931.
238. [238] Faintuch, J., Horie, L.M., Barbeiro, H.V., Barbeiro, D.F., Soriano, F.G., Ishida, R.K., et al. Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obes. Surg. 17 (2007), 341–347.
239. [239] Paschos, G.K., Zampelas, A., Panagiotakos, D.B., Katsiougiannis, S., Griffin, B.A., Votteas, V., et al. Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men. Eur. J. Nutr. 46 (2007), 315–320.
240. [240] Rallidis, L.S., Paschos, G., Liakos, G.K., Velissaridou, A.H., Anastasiadis, G., Zampelas, A., Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167 (2003), 237–242.
241. [241] Din, J.N., Aftab, S.M., Jubb, A.W., Carnegy, F.H., Lyall, K., Sarma, J., et al. Effect of moderate walnut consumption on lipid profile, arterial stiffness and platelet activation in humans. Eur. J. Clin. Nutr. 65 (2011), 234–239.
242. [242] Gladine, C., Meunier, N., Blot, A., Bruchet, L., Pages, X., Gaud, M., et al. Preservation of micronutrients during rapeseed oil refining: a tool to optimize the health value of edible vegetable oils? Rationale and design of the Optim'Oils randomized clinical trial. Contemp. Clin. Trials 32 (2011), 233–239.
243. [243] Baxheinrich, A., Stratmann, B., Lee-Barkey, Y.H., Tschoepe, D., Wahrburg, U., Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of alpha-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Br. J. Nutr. 108 (2012), 682–691.
244. [244] Khalatbari Soltani, S., Jamaluddin, R., Tabibi, H., Mohd Yusof, B.N., Atabak, S., Loh, S.P., et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial. Int. 17 (2013), 275–281.
245. [245] Goyens, P.L., Mensink, R.P., Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects. Eur. J. Clin. Nutr. 60 (2006), 978–984.
246. [246] Shearer, G.C., Savinova, O.V., Harris, W.S., Fish oil -- how does it reduce plasma triglycerides?. Biochim. Biophys. Acta 2012 (1821), 843–851.
247. [247] Harris, W.S., n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65 (1997), 1645S–1654S.
248. [248] Lichtenstein, A.H., Ausman, L.M., Carrasco, W., Jenner, J.L., Gualtieri, L.J., Goldin, B.R., et al. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet. Arterioscler. Thromb. 13 (1993), 1533–1542.
249. [249] Berry, E.M., Hirsch, J., Does dietary linolenic acid influence blood pressure?. Am. J. Clin. Nutr. 44 (1986), 336–340.
250. [250] Salonen, J.T., Salonen, R., Ihanainen, M., Parviainen, M., Seppanen, R., Kantola, M., et al. Blood pressure, dietary fats, and antioxidants. Am. J. Clin. Nutr. 48 (1988), 1226–1232.
251. [251] Caligiuri, S.P., Aukema, H.M., Ravandi, A., Guzman, R., Dibrov, E., Pierce, G.N., Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an alpha-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension 64 (2014), 53–59.
252. [252] Appel, L.J., Miller, E.R. 3rd, Seidler, A.J., Whelton, P.K., Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med. 153 (1993), 1429–1438.
253. [253] Morris, M.C., Sacks, F., Rosner, B., Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88 (1993), 523–533.
254. [254] Miller, P.E., Van Elswyk, M., Alexander, D.D., Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am. J. Hypertens. 27 (2014), 885–896.
255. [255] Needleman, P., Wyche, A., Raz, A., Platelet and blood vessel arachidonate metabolism and interactions. J. Clin. Invest. 63 (1979), 345–349.
256. [256] Knapp, H.R., Reilly, I.A., Alessandrini, P., FitzGerald, G.A., In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N. Engl. J. Med. 314 (1986), 937–942.
257. [257] Egert, S., Baxheinrich, A., Lee-Barkey, Y.H., Tschoepe, D., Wahrburg, U., Stratmann, B., Effects of an energy-restricted diet rich in plant-derived alpha-linolenic acid on systemic inflammation and endothelial function in overweight-to-obese patients with metabolic syndrome traits. Br. J. Nutr. 112 (2014), 1315–1322.
258. [258] Calder, P.C., Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 2015 (1851), 469–484.
259. [259] Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, R.O. 3rd, Criqui, M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003), 499–511.
260. [260] Hu, F.B., Cho, E., Rexrode, K.M., Albert, C.M., Manson, J.E., Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 107 (2003), 1852–1857.
261. [261] Bemelmans, W.J., Lefrandt, J.D., Feskens, E.J., van Haelst, P.L., Broer, J., Meyboom-de Jong, B., et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur. J. Clin. Nutr. 58 (2004), 1083–1089.
262. [262] Thies, F., Miles, E.A., Nebe-von-Caron, G., Powell, J.R., Hurst, T.L., Newsholme, E.A., et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36 (2001), 1183–1193.
263. [263] Paschos, G.K., Rallidis, L.S., Liakos, G.K., Panagiotakos, D., Anastasiadis, G., Votteas, V., et al. Background diet influences the anti-inflammatory effect of alpha-linolenic acid in dyslipidaemic subjects. Br. J. Nutr. 92 (2004), 649–655.
264. [264] Caligiuri, S.P., Aukema, H.M., Ravandi, A., Pierce, G.N., Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption. Exp. Gerontol. 59 (2014), 51–57.
265. [265] Kelley, D.S., Branch, L.B., Love, J.E., Taylor, P.C., Rivera, Y.M., Iacono, J.M., Dietary alpha-linolenic acid and immunocompetence in humans. Am. J. Clin. Nutr. 53 (1991), 40–46.
266. [266] Thies, F., Nebe-von-Caron, G., Powell, J.R., Yaqoob, P., Newsholme, E.A., Calder, P.C., Dietary supplementation with gamma-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J. Nutr. 131 (2001), 1918–1927.
267. [267] Thies, F., Nebe-von-Caron, G., Powell, J.R., Yaqoob, P., Newsholme, E.A., Calder, P.C., Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged > 55 y. Am. J. Clin. Nutr. 73 (2001), 539–548.
268. [268] Walker, C.G., Jebb, S.A., Calder, P.C., Stearidonic acid as a supplemental source of omega-3 polyunsaturated fatty acids to enhance status for improved human health. Nutrition 29 (2013), 363–369.
269. [269] De Spirt, S., Stahl, W., Tronnier, H., Sies, H., Bejot, M., Maurette, J.M., et al. Intervention with flaxseed and borage oil supplements modulates skin condition in women. Br. J. Nutr. 101 (2009), 440–445.